comparemela.com

Latest Breaking News On - Parag kale - Page 1 : comparemela.com

Share Market Highlights 2nd April 2024: Sensex, Nifty retreat after three-day rally; profit-taking dominates

Share Market Highlights 2nd April 2024: Sensex, Nifty retreat after three-day rally; profit-taking dominates
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Jodhpur
Rajasthan
India
Netherlands
Telangana
Andhra-pradesh
Thailand
Morbi
Gujarat
Nigeria
Himachal-pradesh
Uttarakhand

Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
Japan
United-states
Canada
Switzerland
Brazil
Christine-regan-lindenboom
Parag-kale
Josh-brodsky
Renan-denoncourt

Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

30.09.2022 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from exploratory endpoints and additional analyses of prespecified patient subgroups for the primary and secondary endpoints in the APOLLO-B . Seite 1

Parag-kale
Alnylam-pharmaceuticals-inc
Nasdaq
Alnylam-pharmaceuticals
Heart-failure-society
Annual-scientific-meeting
International-symposium
Staff-cardiologist
Heart-transplant-department
Baylor-university-medical

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Japan
Cambridge
Cambridgeshire
United-kingdom
United-states
Canada
Switzerland
Brazil
Christine-regan-lindenboom
Parag-kale
Josh-brodsky
Renan-denoncourt

Alnylam to Present Additional Data from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at the Heart Failure Society of America Annual Scientific Meeting 2022

13.09.2022 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company will present additional data from the APOLLO-B Phase 3 study of patisiran, an investigational RNAi therapeutic in development for . Seite 1

Parag-kale
Mathew-maurer
Primary-results
Transthyretin-mediated-amyloidosis
Mat-maurer
Arlene-goldstein-professor
Columbia-university
Alnylam-pharmaceuticals

vimarsana © 2020. All Rights Reserved.